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ABSTRACT
Duchenne muscular dystrophy (DMD) is a progressive
neuromuscular disorder characterized by muscle wasting and
premature death. The defective gene is dystrophin, a structural
protein, absence of which causes membrane fragility and myofiber
necrosis. Several lines of evidence showed that in adult DMD patients
dystrophin is involved in signaling pathways that regulate calcium
homeostasis and differentiation programs. However, secondary
aspects of the disease, such as inflammation and fibrosis
development, might represent a bias in the analysis. Because fetal
muscle is not influenced by gravity and does not suffer from
mechanical load and/or inflammation, we investigated 12-week-old
fetal DMD skeletal muscles, highlighting for the first time early
alterations in signaling pathways mediated by the absence of
dystrophin itself. We found that PLC/IP3/IP3R/Ryr1/Ca2+ signaling
is widely active in fetal DMD skeletal muscles and, through the
calcium-dependent PKCα protein, exerts a fundamental regulatory
role in delaying myogenesis and in myofiber commitment. These data
provide new insights into the origin of DMD pathology during muscle
development.
KEY WORDS: DMD fetus, Dystrophin signaling, Calcium channels,
IP3/IP3R pathway, Myosin isoforms
INTRODUCTION
Duchenne muscular dystrophy (DMD) is the most severe form of
muscular dystrophy. In the early phase of the disease, the skeletal
muscle of DMD patients is characterized by an ongoing process of
degeneration and regeneration followed by exhaustion of its
regenerative capacity, that leads to infiltration of inflammatory
cells, fibrosis and finally to the disruption of the muscle tissue
architecture (Emery, 2002). Although the dystrophin gene was
discovered almost 30 years ago, an effective therapy has not yet
been found. The membrane fragility, consequent to dystrophin
absence, does not fully explain the divergent expression signature of
both dystrophic mice (mdx) and DMD patients at different stages of
the disease versus healthy muscles in terms of muscle wasting,
inflammation and fibrosis (Chen and Ende, 2000; Boer et al., 2002;
Porter et al., 2002). Transcriptomic analysis of dystrophic fibers
revealed modification or upregulation of genes involved in calcium
handling, probably related to altered stability of dystrophin-
associated proteins (DAPs), in metabolism, extracellular matrix
genes and genes implicated in inflammatory response (Lapidos
et al., 2004). It was demonstrated that dystrophin could interact with
nitric oxide synthase and syntrophin [regulating other proteins
involved in calcium homeostasis (Brenman et al., 1996; Taghli-
Lamallem et al., 2014)] and with calmodulin in a calcium-
dependent manner (Anderson et al., 1996). These studies
suggested that dystrophin interactions were required for signal
transduction at the membrane but, more importantly, that dystrophin
itself modulated different signaling pathways. The inflammation,
macrophage infiltration, degenerating and regenerating fibers, and
stretch-induced damage are commonly described in DMD as
secondary pathology and might interfere with analysis of
dystrophin-related pathways (Boer et al., 2002).
Gharamani et al. partially resolved this issue by silencing the
dystrophin gene, through stable RNA interference, in C2C12 cells:
they demonstrated a multitude of de-regulated pathways involving
calcium homeostasis, ion channels, metabolism and muscle
contractile unit organization (Ghahramani Seno et al., 2010).
However, this in vitro model does not recapitulate the complex
architecture of mechanically and electrically stimulated muscle.
Fetal muscle is not influenced by gravity and does not suffer from
mechanical load and/or inflammation; it therefore represents a
valuable model in which to elucidate the primary role of dystrophin
in regulating not only the structure of membranes but also Ca2+
homeostasis and modulation of signaling/metabolic pathways.
Taking into account different studies describing how dystrophin
absence causes an undifferentiated state of myofibers or, at least, an
altered or delayed differentiation program (Chen and Ende, 2000),
which is evident in mdx embryos (Merrick et al., 2009) and DMD
patients (Pescatori et al., 2007), we also investigated whether its
absence eventually impaired myogenesis.
Deval et al. suggested that increased calcium release from the
sarcoplasmic reticulum (SR) is involved in calcium dysregulation in
DMDmyotubes (Deval et al., 2002). The high sensitivity to calcium
of dystrophic muscle cells is dependent on two specialized
intracellular Ca2+-releasing channels located at the SR membrane:
the ryanodine receptor 1 (Ryr1) and inositol 1,4,5-trisphosphate
(IP3) receptors (IP3Rs) (Carrasco and Figueroa, 1995; Imbert et al.,
1996). Recently, Bellinger et al. identified a structural and
functional defect in Ryr1 in mdx muscles (Bellinger et al., 2009),
and Morel and others suggested that Ryr1 expression could be
altered also in vascular myocytes of mdx mice (Morel et al., 2009).
Finally, Andersson et al. hypothesized that leaky Ryr1 channels
could underlie multiple forms of muscular dystrophy linked toReceived 6 May 2015; Accepted 24 December 2015
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mutations in genes encoding components of the dystrophin-
glycoprotein complex (Andersson et al., 2012). Moreover, a
previous study showed that basal levels of IP3 were increased
two- to three-fold in dystrophic human and murine cell lines
compared with normal cell lines (Liberona et al., 1998). As IP3
production is induced by phospholipase C (PLC) activation, it was
reported that dystrophin absence determines increased PLC activity
and IP3 production (Mondin et al., 2009; Sabourin et al., 2012).
The calcium signaling cascade could activate a proteolytic
pathway leading to myofiber necrosis, as demonstrated by delayed
onset of dystrophic symptoms in mdx mice after chronically
blocking calcium channels in utero (Jørgensen et al., 2011), or
modulate myogenic expression (Bassel-Duby and Olson, 2006).
Cell fate after intracellular calcium accumulation depends on the
ability of calcium decoders to promote gene expression (Tavi and
Westerblad, 2011). Multiple calcium decoders are known and
among them calmodulin, calcineurin and protein kinase C (PKC)α
exert a fundamental role in skeletal myofibers (Gundersen, 2011)
through the activity of nuclear factor of activated T cells (NFAT)
and histone deacetylases (HDACs) on myogenic regulating factors
(MRFs) (Liu et al., 2005; Shen et al., 2006). Extending these
findings to pathological cardiac growth, several papers
demonstrated that Ca2+ released from IP3-dependent pathways
activates nuclear calmodulin-dependent protein kinase-II (CaMKII)
(Kawaguchi et al., 1993; Nakayama et al., 2010) and, consequently,
the cardiac gene program (Anderson et al., 2011). Calcium
transients can induce both fast and slow changes, according to the
specific calcium sensor involved. This phenomenon, known as
muscle plasticity, is important in muscle architecture remodeling
both in physiological and pathological conditions, such as in
muscular dystrophies.
In our work, we found that in fetal DMD skeletal muscles IP3/
Ca2+ signaling is widely expressed and, through PKCα-calcium
sensors, exerts a fundamental regulatory role in delaying
myogenesis and in myofiber commitment. As this pathway is
different from those described in adult muscle, we highlighted the
difference underlying primary and secondary pathologies that
characterize DMD skeletal muscles. Furthermore, these data might
explain the contradictory results observed when other groups tried
to compare different models such as myoblasts/myotubes or whole
muscles. Our evidence suggests the calcium-related pathway is
activated differently in fetal and adult DMD skeletal muscle fibers.
RESULTS
Characterization of 12-week-old human fetal normal and
dystrophic muscles
We performed histological evaluation of muscular biopsies from
12-week-old DMD and healthy (CTR) fetuses. Hematoxylin and
Eosin (H&E) analysis and Azan Mallory (AM) staining did not
reveal any difference in fiber morphology or in development of
connective tissues: in particular, no sign of necrosis or muscular
damage was observed (Fig. 1A). However, in DMD muscular
biopsies we found a reduction in fiber density, as seen by a
significant increase in the proportion of extracellular matrix
(percentage of extracellular matrix±s.d.: CTR 16.65±1.084 and
DMD 26.99±1.444, P<0.0001; Fig. 1B), and a reduction, although
not significant, of the proportion of myofibers per area (Fig. 1C).
Interestingly, we calculated the difference between total section area
and myofiber area and we confirmed the reduction of myofiber-
filled space in DMD biopsies (total section area−myofiber area:
CTR 82,463±5914 µm2 and DMD 135,498±7946 µm2, P<0.0001).
To analyze further the developmental stage of DMD and CTR
muscles, we characterized myosin heavy chain (MyHC) expression
(Fig. 1D). Immunofluorescence analysis showed significant
differences in expression of myosin isoforms in DMD versus
healthy fetal muscles as demonstrated by a reduced percentage
of developmental (MyHC-dev: CTR 90.76±1327% and DMD
82.92±2.032%, P=0.0052; Fig. 1E) and neonatal (MyHC-neo: CTR
90.43±1.413% and DMD 84.79±1.783%, P=0.0247; Fig. 1F)
positive myofibers. Also the percentage of mature fibers
(MyHC-slow and -fast positive) was altered (MyHC-fast: CTR
55.11±4.077% and DMD 67.2±3.113%, P=0.0315; MyHC-slow:
CTR 63.15±2.634% and DMD 29.16±0.867%, P<0.0001;
Fig. 1G,H). To understand these data better, we performed co-
immunostaining of fast and slow MyHC to analyze the proportion
of these fiber types in human biopsies. Morphometric analysis
revealed a reduction in the cross-sectional area (CSA) of fast
myofibers in DMD muscles (mean±s.e.m.; CSA: CTR 5.967±
0.393 pixels and DMD 4.269±0.121 pixels, P<0.0001), whereas the
CSA of slowmyofibers was comparable to that of slowmyofibers of
CTR muscles (mean±s.e.m.; CTR 7.306±0.356 pixels and DMD
6.838±0.2392 pixels) (Fig. 2A,B). More interestingly, differences
arose regarding the number of myofibers expressing fast and slow
MyHC isoforms. In particular, the number of myofibers expressing
slow MyHC was significantly higher in control than in dystrophic
fetal muscle (percentage of total fibers±s.d.: CTR 57.4±7.2% and
DMD 23.5±6.2%). Accordingly, fast MyHC was detected in
62±7.9% of dystrophic myofibers, whereas only 37.5±6.4% of
control myofibers expressed fast myosin. The differences in
expression of each MyHC isoform were statistically significant
(Fisher’s exact test: P<0.0001 for fast and slow myofibers). This
tendency was confirmed by western blot (WB) experiments
(Fig. 2D). Hybrid myofibers co-expressing fast and slow MyHC
were also detected, accounting for 5.1±1.9% and 14.5±5.2% of total
myofibers in control and DMD fetal muscles, respectively (Fig. 2C).
Interestingly, we demonstrated by real-time quantitative PCR (RT-
qPCR) that myofiber gene expression is altered in dystrophic fetal
muscles, as they expressed a significantly higher level of fast-type
genes, such as sarcoplasmic reticulum calcium ATPase-1 (ATP2A1)
(P=0.092), troponin T type 3 (skeletal, fast) (TNNT3) (P=0.0678)
and, although not significant, troponin fast C type 2 (TNNC2).
Conversely, they expressed significantly lower levels of
slow-type genes, such as slow myosin heavy chain 2 (MYHC-
SL2) (P=0.0136), the troponin T type 1 (skeletal, slow) (TNNT1)
(P=0.03) and, although not significant, creatine kinase
mitochondrial 2 (CKMT2) (Fig. 3A). As it has been demonstrated
that SIX genes are the master regulators for the differential
activation of specific muscle programs, and in particular the
central switch to drive the skeletal muscle fast phenotype during
fetal development, we investigated the expression of SIX genes and
also of EYA genes, which interact synergistically with them, by RT-
qPCR. However, we did not find any appreciable difference
between human healthy and dystrophic fetal muscles (Fig. 3B). It
has been shown that in mammals, embryonic skeletal muscle
differentiation arose from two different myogenic waves, which
generate firstly primary and, subsequently, secondary myotubes,
from which newly formed muscle arises (Cossu et al., 1996;
Merrick et al., 2009). At this stage of development, different myosin
isoforms are co-expressed depending on the specificity of function
of individual skeletal muscle groups (Cho et al., 1994; Merrick
et al., 2007). According to our data, the abnormal expression of fast
and slow isoforms that we described in DMD fetal muscles could be
attributed to an uncontrolled fiber type switch or to a developmental
delay between primary and secondary myogenesis. Nevertheless,
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taken together with the reduction of the CSA of fast myofibers
(Fig. 2A,B) and the significantly increased proportion of
extracellular matrix (Fig. 1B) in dystrophic muscles, we suggest a
delay in maturation of DMD fetal muscles.
Expression of myogenicmarkers in 12-week-old human fetal
healthy and dystrophic muscles
As myofibers develop from Pax7+ muscle progenitors that migrate
from the central dermomyotome (Relaix et al., 2005), we
investigated the expression of PAX7 and we showed a
significantly higher number of PAX7+ cells per myofiber in DMD
samples compared with healthy samples (CTR 2.313±0.246 and
DMD 3.446±0.0254, P=0.0445) (Fig. 4A,B), and we demonstrated
by WB analysis a significantly higher expression of PAX7 protein
(CTR 0.393±0.0518 and DMD 1.032±0.1362, P=0.0183)
(Fig. 4C). As it is known that Pax3 is an important determinant of
embryo myogenesis and Pax7+ cells derive from Pax3+ cells during
and after somitogenesis, we investigated its expression in murine
and human dystrophic fetal muscles. Pax3 expression was found in
neither fetal murine mdx (E18.5) nor DMD 12-week-old fetal
muscles (data not shown). The RT-qPCR analysis and, more
interestingly, the WB analysis, demonstrated the downregulation of
MYOD expression in DMD muscles (Fig. 4D,E) (P=0.0206 and
P=0.0057, respectively).
Calcium measurement in fetal muscles
As calcium overload is one of the major features in DMD
pathogenesis, we analyzed the calcium content of muscles from 12-
week-old DMD and CTR fetuses. Previous works reported that fetal
DMD muscles were histologically normal except for occasional
eosinophilic hypercontracted fibers (Bertorini et al., 1984; Lotz and
Engel, 1987). Therefore, we performed Alizarin Red (AR) staining
and observed a consistently higher accumulation of Ca2+ in DMD
fetal muscles than in healthy samples (Fig. 5A). Staining
quantification demonstrated a fourfold increase of intracellular
calcium in DMD versus CTR myofibers (DMD 43.01±6.055%
versus CTR 14.8±2.752%, P=0.0008) (Fig. 5A′). Calcium
accumulation was also confirmed by Fluo-4 staining (Fig. 5B,B′).
As this event in dystrophic muscle is thought to be crucial for caspase
activation, we performed immunofluorescence analysis of active
caspase 3 and we demonstrated that calcium levels were not related to
either necrosis or caspase 3 activation (Fig. 5C). Furthermore, we
performed alkaline phosphatase (AP) to stain regenerating fibers in
adult muscles and we found that the majority of DMD and healthy
fetal myofibers were AP positivewithout differences in the number of
stained myofibers between specimens, consistent with the fact that
regenerating fibers recapitulate maturative steps of developing fibers
duringmyogenesis. However, theAP staining intensitywas increased
in fetal DMD myofibers, suggesting a more immature myofiber
Fig. 1. Altered muscular architecture in
DMD fetal myofibers. (A) H&E staining
revealed similar myofiber morphology between
CTR and DMD muscles. No signs of necrosis
or sarcolemma damage were visible. AM
staining revealed a similar level of collagen
deposition between CTR and DMD muscle
sections. However, increased extracellular
matrix deposition was observed in DMD tissue.
Scale bars: 40 µm. (B,C) Histograms
representing the myofiber density of CTR and
DMD fetal muscles, calculated as the
extracellular matrix (ECM; i.e. the white space
between the myofibers) versus myofiber area
(B) and as the number of myofibers
presented in a fixed grid area (C).
(D) Immunofluorescence analysis of muscle
sections stained with antibodies against MyHC
isoforms (red) and laminin (green). Nuclei were
identified with DAPI (blue). (E-H) CTR fetal
muscles show a higher percentage of MyHC-
developmental, -neonatal and -slow positive
myofibers (E,F,H) and a lower percentage of
MyHC-fast positive myofibers (G) than DMD
fetal muscles (percentage of laminin-positive
myofibers that are MyHC positive). Data are
expressed as mean±s.d.; *P<0.05, **P<0.005,
***P<0.001.
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phenotype. Interestingly, we showed that higher content of calcium
was common to slow/fast and hybrid myofibers (Fig. 5C,D).
Characterization of C57BL/6J and mdx fetal muscles
To identify the source of calcium overload it was necessary to
investigate various membrane ion channels. We focused on the
major Ca2+ channels and those identified as altered in dystrophic
muscles (both in murine and in human muscles). Thus, we decided
to perform an initial screening in mouse fetal muscle tissues and, in
a second step, we investigated in human fetal muscles only those
channels that were altered in dystrophic murine muscles. This
selection process allowed the best use of the human fetal tissue
available. First of all, we demonstrated that calcium overload was
also present in mdx fetuses. Fluo-4 staining confirmed calcium
Fig. 3. Evaluation of gene expression in CTR and DMD
fetal muscles. (A,B) Quantitative PCR experiments
performed on CTR and DMD fetal muscles. Relative
expression values revealed significant differences in the
expression of fast- (ATP2A1, TNNC2, TNNT3) and slow-
(MYHC-SL2, CKMT2, TNNT1) type genes (A) and no
significant differences in the expression of SIX and EYA
genes (B). Data are expressed as mean±s.d. *P<0.05.
Fig. 2. Fast and slow fiber-type specification is altered in DMD fetalmuscles. (A) Immunostaining in 12-week-old DMD andCTR fetal muscles that allowed us
tomeasure the proportion of fast fibers (pink) and slow fibers (gray) per section. (B) Slow-myofiber areawas similar betweenCTR and DMDbut fast-myofiber area
was significantly higher in CTR versus DMD tissue (slow: 25th percentile CTR 3.0, DMD 3.6; median, CTR 6.45 DMD 6.975; 75th percentile CTR 10.95, DMD
9.78) (fast: 25th percentile CTR 2.25, DMD 2.43; median CTR 4.8, DMD 3.6; 75th percentile CTR 8.13, DMD 5.4) (P<0.0001). (C) Histogram showing the
proportion of each MyHC isoform in a fixed grid area in DMD and CTR fetal muscles. (D) WB analysis of the expression of MyHC slow and fast demonstrating a
higher expression of MyHC fast in dystrophic samples. Adult human healthy muscle was used as positive control (Pos CTR) and water was used as negative
control (Neg CTR) to avoid false positives deriving from buffer contamination. Data are expressed as mean±s.d.; ****P<0.0001.
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accumulation in myofibers from embryonic day (E) 18 mdx fetuses
while no Ca2+ accumulation was observed in C57BL/6J fetal
muscles (Fig. 6). Desmin staining of serial sections confirmed that
the calcium accumulation was relative to myofibers (Fig. 6).
Expression of Ca2+ channels in murine fetal muscle tissues
To analyze the possible origin of the calcium overexpression in
dystrophic muscles, we investigated the expression level ofOrai1, the
pore-forming unit of store-operating Ca2+ channels (SOCE), and of
another component of the SOCE complex, the stromal interaction
molecule 1 (Stim1). RT-qPCR showed that there was an increase in
mRNA expression of these genes in the mdx fetuses, but only Orai1
was statistically significant (C57BL/6J 0.1733±0.037 and mdx
4.75±1.15, P=0.0129) (Fig. 7A). Moreover, we evaluated through
WB the expression of other proteins, such as Ryr1 and Trpc1, and we
found that Ryr1 was significantly overexpressed in mdx mice
(C57BL/6J 0.2232±0.041 and mdx 0.5216±0.057, P=0.0133)
(Fig. 7B), but Trpc1 expression did not change significantly
(Fig. 7C). As Ryr1 and IP3R belong to the same class of calcium
channels and intracellular calcium increase can be mediated by
IP3/IP3R binding, we firstly investigated the expression of IP3R in
murine fetal muscles by WB analysis. We observed a significant
higher concentration of IP3R in dystrophic fetal muscles (C57BL/6J
0.3299±0.051 and mdx 0.9917±0.1897, P=0.0281) (Fig. 7D).
Moreover, we demonstrated by ELISA that mdx muscles expressed
higher levels of IP3 related to C57BL/6J samples (C57BL/6J 96.58±
3.449 pg/ml and mdx 141.2±8.283 pg/ml, P=0.0001) (Fig. 7E),
suggesting an over-activity of PLC in dystrophic fetal muscle tissues.
Expression of Ca2+-dependent protein inmurine fetal muscle
tissues
Among the plethora of proteins that are regulated by calcium
concentration, Ca2+-calmodulin-dependent protein kinase II
(CaMKII) regulates gene expression in cardiac and skeletal
Fig. 4. Increased PAX7 expression in DMD
fetal muscles. (A,B) Human dystrophic (DMD)
and healthy (CTR) muscles were stained with
antibodies against PAX7 (red) and desmin
(green) (A) and we demonstrated an increase
of the ratio PAX7+ nuclei/total number of
myofibers in DMD samples (B). Insets show
higher magnification images. Scale bars:
150 μm. (C) Analysis of Pax7 expression by
WB revealed a higher expression of PAX7 in
dystrophic samples as shown by densitometric
analysis. (D,E) RT-qPCR (D) and WB (E)
analyses showed downregulation of MYOD
expression in DMD fetal muscles. RH30
rabdomyosarcoma cells were used as positive
control (Pos CTR). Data are expressed as
mean±s.d.; *P<0.05, **P<0.005.
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muscle. As suggested by Kramerova et al. (2012), we evaluated the
expression of this protein in our samples and we showed that there is
a little but not significant increase of CaMKII in mdx fetal muscle
tissues (Fig. 7F). Considering the evidence obtained by Wang et al.
(2009), Madaro et al. (2012) and the work of Kawasaki,
demonstrating the role of PKC in the phosphorylation of Orai1
(Kawasaki et al., 2010), we decided to investigate the expression of
PKCα in murine fetal muscle tissues. In skeletal muscle, PKCα
Fig. 5. Ca2+ accumulation in DMD fetal biopsies.
(A) AR staining demonstrated an increased calcium
deposition in DMD versus healthy CTR myofibers
(where no positive myofibers were observed). Scale
bars: 40 µm. AP staining showsmyofibers in skeletal
muscle. Scale bars: 50 μm. (B) Fluo-4 staining
confirmed calcium accumulation in DMD fetal
muscles. Histograms representing the quantification
of AR and Fluo-4 staining in CTR and DMD fetal
muscles are shown in A′ and B′, respectively. Data
are expressed asmean±s.d.; ***P<0.001. Scale bar:
50 μm. (C) Immunofluorescence staining of active
Caspase-3 (green). Jurkat cell line treated with 2 μM
camptothecin was used as positive control.
Myofibers were stained with Desmin (red); no sign of
caspase-3 activation was observed in dystrophic or
healthy myofibers, suggesting that calcium overload
did not promote apoptotic cascade. The majority of
DMD and healthy fetal myofibers were AP positive
without differences in the number of stained
myofibers between specimens. It is interesting that
AP staining is more intense in DMD myofibers,
suggesting a delay in their myogenesis.
(D) Immunohistochemistry (top panels) on DMD
muscle serial sections for fast (pink) and slow (gray)
myofibers and immunofluorescence (middle panels)
for slow MyHC (red) and desmin (green) expression
confirm that both fast and slow MyHC myofibers are
calcium enriched as visualized with AR staining
(bottom panels). Boxed areas labeled A and B are
shown at higher magnification (40× magnification
vs. 10×) in the corresponding panels on the right.
Arrows indicate the same cluster of slow MyHC
myofibers in each panel. Arrows indicate the same
cluster of slowMyHCmyofibers in each panel. Scale
bars: 200 μm (50 μm for enlargements).
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protein is regulated by Ca2+ concentration and plays a fundamental
role in muscle development and plasticity (Gundersen, 2011).
Because PKCα exerts its function when phosphorylated, we
measured the phospho-PKCα/total PKCα ratio for each sample to
avoid any bias deriving from differences in muscle content between
samples. Interestingly, we found that the phospho-PKCα/total
PKCα ratio was significantly higher in dystrophic than healthy
samples (P=0.0025; Fig. 7G).
Overexpression of PKCα in human fetal dystrophic muscle
In accordance with the results obtained in murine fetuses,
we demonstrated a significant increase of RYR1 expression in
human fetal dystrophic samples (CTR 0.466±0.07423 and DMD
1.143±0.2332, P=0.0199) (Fig. 8A) and, more interestingly, of
IP3R by WB (CTR 0.3826±0.03879 and DMD 0.9122±0.096,
P=0.0015) (Fig. 8B) and IP3 by ELISA analysis (Fig. 8C).
Furthermore, we observed that the phospho-PKCα/total PKCα ratio
was significantly higher in human dystrophic fetal muscles than in
healthy ones (Fig. 8D,E; P=0.008). A more sensitive approach was
required to improve analysis regarding PKCα activation. The most
common assay for kinases, measuring the transfer of radioactive
phosphate to a substrate protein or peptide, is effective but
inconvenient and hazardous owing to the large quantity of 32P
used. To circumvent these difficulties, we turned to the PepTag
Assay, which is sensitive to a variety of different PKC isoforms (α,
β, γ, µ). Although only PKCα is known to be muscle specific, recent
evidence suggests that PKCεmight also act in this tissue (Niu et al.,
2011). To avoid biases related to the presence of multiple PKC
isoforms, the expression of PRKCE (the gene encoding PKCε) in
human healthy and dystrophic fetal muscles was assessed using RT-
qPCR. PRKCE transcript was barely detectable in all samples tested
(data not shown). Performing the PepTag Assay, we confirmed that
the ratio of phosphorylated PKCα to total PKCα was significantly
higher in DMD fetal muscle samples than in healthy ones
(P=0.0115; Fig. 8F).
DISCUSSION
Thirty years after the discovery of the dystrophin gene, the
molecular bases of DMD pathophysiology are still unknown. In
particular, understanding whether the absence of only one protein
results in such a complicated phenotype remains a challenge. The
mechanical susceptibility of dystrophic myoﬁbers is a well-known
phenomenon leading tomyofiber damage and necrosis. The scaffold
of DAPs, through the assembly of multiprotein signaling
complexes, regulates suppressors of cytokine signaling (SOCs)
and IP3Rs, with important consequences in maintaining normal
calcium homeostasis in the skeletal muscle cell. The lack of
dystrophin and the consequent disorganization of the membrane-
associated cytoskeleton could induce a dysfunction of calcium
inﬂuxes and releases, with cumulative consequences on fetal DMD
myogenesis, and adult muscle damage. However, dystrophin
absence might be more crucial, and might not simply unbalance
the mechanical structure of plasma membrane but deeply modify
gene expression, as suggested by previously published
transcriptomic analysis of dystrophic muscles (Haslett et al., 2003;
Ghahramani Seno et al., 2010).
In this work, we investigated fetal DMD skeletal muscle
development in order to improve our understanding of the
primary pathology in the absence of inflammation or fibrosis and
under reduced mechanical load. In adult muscles, dystrophin and
α-syntrophin regulate PLC activity by stabilizing the sarcolemma;
thus, dystrophin absence leads to increased PLC activity (Jordan
et al., 2004; Mondin et al., 2009; Sabourin et al., 2012).
Furthermore, previous studies showed that dystrophic human
samples and murine cell lines expressed high levels of IP3
compared with normal cell lines (Liberona et al., 1998; Mondin
et al., 2009) and IP3-induced Ca2+ release altered gene expression
regulation (Powell et al., 2001; Araya et al., 2003). In addition, it
was determined that modifications in the metabolism of IP3 were
fundamental at different stages of muscle development (Carrasco
et al., 1997), and others suggested a role for IP3/IP3R during
skeletal myocyte development (Rosemblit et al., 1999) and in
cardiomyocyte hypertrophy (Arantes et al., 2012). Therefore, we
investigated IP3R and IP3 pathway, demonstrating their over-
activity in fetal DMD muscle. IP3R belongs to the same class of
receptors as RYR1, and IP3/IP3R binding determines calcium cell
accumulation as we observed in DMD fetal biopsies (Fig. 9).
Calcium entry could also be regulated through amultitude of SOCs:
α1-syntrophin and PKCα could balance the activity of Stim1/
Orai1/Trpc1 genes (Sabourin et al., 2012; Harisseh et al., 2013). In
addition to altered expression of Orai1, we observed an
overexpression of Trpc1 and Ryr1, in accordance with previously
reported data (Carrasco and Figueroa, 1995; Imbert et al.,
1996; Bellinger et al., 2009; Morel et al., 2009; Andersson et al.,
2012). Calcium concentration has a well-known importance in the
development of DMD pathogenesis. However, some controversies
arose regarding the elevation of steady-state cytosolic calcium
levels in DMD muscles, as it was observed in muscles and
myofibers (Bakker et al., 1993; Denetclaw et al., 1994) even though
it was not definitely confirmed in cultured mdx or DMD myotubes
(Gailly et al., 1993; Head, 1993; Pressmar et al., 1994; Collet et al.,
1999). Imbert and colleagues suggested that elevated steady-state
calcium levels observed in well-differentiated DMD myotubes co-
cultured with neural explants were due to specific calcium channels
during muscle spontaneous activity (Imbert et al., 1995). By
contrast, DMD myotubes in primary culture did not develop a
signiﬁcant increase in calcium (Rivet-Bastide et al., 1993; Pressmar
et al., 1994), suggesting involvement of a different Ca2+ pathway.
Calcium signaling is involved in a multitude of muscular pathways
that lead to modification of gene expression and, especially in
DMD, to myofiber injury (Alderton and Steinhardt, 2000). In
particular, it was suggested that a persistent intake of Ca2+ activates
Ca2+-sensitive proteolytic and phospholipolytic activities, resulting
in the degradation of dystrophic muscle ﬁbers (Alderton and
Steinhardt, 2000). However, we did not observe any evidence of
fiber degeneration, apoptotic activation, or alteration in the number
Fig. 6. Ca2+ accumulation inmyofibers of E18 lower limbs of mdx fetuses.
Fluo-4 staining demonstrated increased calcium deposition in fetal mdx versus
C57BL/6J myofibers (where no Fluo-4-positive myofibers were observed).
Immunofluorescence of desmin (green) was performed on serial sections to
confirm that Ca2+ deposition was inside skeletal myofibers (4× magnification).
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of regenerating myofibers. These data suggest that the pathways
involved in fetal muscles are different from those underlying the
adult dystrophic muscle phenotype (Fig. 9). Calcineurin and
CaMKII are Ca2+ decoders that are dependent on calmodulin-Ca2+
binding (Klee et al., 1998; Sakuma and Yamaguchi, 2010) and are
able to alter gene transcription by inducing nucleo-cytoplasmic
shuttling of transcription factors (e.g. NFAT and myocyte enhancer
factor-2, MEF2) (Chen et al., 2001; Liu et al., 2001) and
transcription modulators (histone deacetylases, HDACs) (Liu
et al., 2005; Shen et al., 2006). These enzymes are involved in
muscle plasticity induced by changes in calcium concentration in
response to environmental factors (i.e. aerobic/anaerobic exercise
training or muscular disorders). Once activated by prolonged and
slow electric stimuli determining calcium accumulation, they
promote gene expression towards a slow, oxidative and resistant
phenotype (Chin et al., 1998). Similarly, in adult DMDmuscles the
proportion of slow myosin-expressing fibers is higher than in
healthy muscles. Moreover, it was demonstrated that fast myofibers
in human skeletal muscles are subjected to great stress by the fast-
contraction-relaxation cycle and are most susceptible to mechanical
damage (Bottinelli et al., 1996). This is probably a consequence of
an adaptive response of the body to the muscle disease (Campbell,
1995; Pedemonte et al., 1999). This way, DMD fast myofibers seem
to be the first to degenerate and to be replaced by slow fibers. Fetal
muscle does not require a switch of fiber phenotype into fatigue and
mechanical stress resistance, as it grows in conditions of reduced
gravity and stress. In line with this fetal environment, we
demonstrated inactivity of the Ca2+/calmodulin/CAMKII
pathway. Taken together with the work of Oh and collaborators,
demonstrating that slow fiber expression during embryogenesis and
early postnatal growth is under the control of a developmental
program in a calcineurin-independent manner (Oh et al., 2005), we
investigated the expression level of another calcium-dependent
protein, PKCα. In accordance with previously published data that
demonstrated that PKCα exerted a primary role in pathogenesis of
DMD (Wang et al., 2009; Madaro et al., 2012), we showed its early
overactivation in DMD fetal muscle tissues. PKCα is involved in
signal transduction cascades regulating the proliferation of
myoblasts (Goel and Dey, 2002). Furthermore, PKCα is engaged
in repressing myogenic factors, in particular MyoD (Vaidya et al.,
1991), suggesting its role as a negative modulator of myogenesis
(Capiati et al., 1999). Interestingly, Ryr1 activity had been related to
both PKCα activation and MyHC-slow gene suppression. In
addition, muscle PKCα once activated translocates to the nucleus
and interacts with MRFs (Cleland et al., 1989; Huang et al., 1992),
and it was demonstrated in the avian models that PKCα activity was
higher in fast than in slow myofibers (DiMario and Funk, 1999;
DiMario, 2001; Jordan et al., 2004). In agreement with these data,
we showed that enhanced PKCα activation resulted in altered
myogenesis, characterized by a delay in fiber maturation and
modification of fiber type composition. We observed a reduction in
the total number of myofibers and a reduction in the proportion of
MyHC-expressing myofibers, and an increase in the proportion of
extracellular matrix. Interestingly, we showed in fetal DMDmuscle
tissues an overexpression of PAX7 and a reduction of MyoD
expression; therefore, we suggest that the differentiation program of
myofibers is delayed. Furthermore, DMD muscles presented a
greater proportion of hybrid (expressing both fast and slow myosin
isoforms) and fast myofibers, and a concurrent reduction of
myofiber size of fast myofibers. These data were confirmed by the
RT-qPCR analysis of relative expression values of several fast-
(ATP2A1, TNNC2, TNNT3) and slow- (MYHC-SL2, CKMT2,
TNNT1) specific genes. Of note, similar findings were reported in
developing fetuses suffering from other neuromuscular disorders
such as spinal muscular atrophy (SMA) (Martínez-Hernández et al.,
2014). However, these observations are in contrast with data
Fig. 7. Modulation of protein expression in mdx fetal muscles. (A) RT-qPCR evaluation of the expression of Orai1 and Stim1 revealed an increase these
genes in mdx fetal muscles. (B-D) WB immunoblot and densitometric quantification analysis of C57BL/6J and mdx E18 fetuses for the expression of Ryr1 (rat
skeletal muscle was used as positive control, Pos CTR) (B), Trpc1 (C57Bl/6J testis was used as positive control) (C) and IP3R (rat cerebellum was used as
positive control) (D). (E) ELISA quantification of IP3 showed higher expression in mdx fetal muscles related to C57BL/6J ones. (F,G) WB analysis of C57BL/6J
and mdx E18 fetal muscles for the expression of total and phosphorylated CaMKII (F) and PKCα (rat cerebrum lysate was used as positive control) (G). Data are
expressed as mean±s.d.; *P<0.05, **P<0.005, ***P<0.001.
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obtained in DMD patients, considering that in adult dystrophic
muscles the number of fibers expressing slowmyosin is higher than
those expressing fast myosin. As discussed above, we supposed that
in adult DMD muscles the sustained and prolonged calcium
accumulation, which derived from membrane tears, membrane
mechanical stretching and inflammation, leads to the activation of
different signaling pathways, resulting in the expression of a more
resistant slow-type phenotype (Higginson et al., 2002; Parsons
et al., 2003, 2004).
Owing to the shortage of human samples from DMD fetuses and
the difficulties in handling such fragile tissue samples, DMD fetal
development was commonly considered to be unaltered. Here, we
demonstrated early pathological pathways in DMD fetal muscles
that differ from those previously described in adult DMD muscles.
According to our data and to the demonstration that PKCα
expression decreases to allow differentiation (Capiati et al., 1999,
2000), we propose that dystrophin absence causes the activation of
a PLC/IP3R/calcium/PKCα pathway during development of DMD
muscle, when no mechanical stress or fiber degeneration are
present. This activation leads to a delay in myofiber maturation and
a rearrangement of the expression of fast/slow-specific genes. From
our knowledge, this is the first evidence that the myo-pathology of
DMD begins with a significant delay of fetal muscle differentiation
at an early fetal stage. Modulation of the IP3/IP3R pathway and
fiber type specification might thus offer a powerful method to limit
the muscle damage of DMD. Further studies exploring the
molecular links between IP3/PKCα and proteins involved in
calcium signaling will help us to understand the interplay between
DAPs and calcium homeostasis, raising the hope for
pharmacologically or genetically modulating each step of the
involved pathways.
MATERIALS AND METHODS
Tissues
Informed consent to use human fetal tissues was obtained according
to the guidelines of the Committee on the Use of Human and
Murine Subjects in Research of Ospedale Maggiore Policlinico di
Milano (Milan, Italy). Twelve-week-old human fetal tissues (n=3)
were obtained anonymously after spontaneous, voluntary or therapeutic
pregnancy terminations. DMD fetuses (n=3) were genetically
characterized by the ‘Centro di Diagnosi Prenatale (Prenatal
Diagnostic Center) Fondazione IRCCS Cà Granda Ospedale Maggiore
Policlinico’. DMD fetuses presented different frameshift mutations of
the dystrophin gene: Δ47-52, Δ12, Δ19. We analyzed the muscles of the
lower limb, selecting the quadriceps for analyses. Mdx (C57BL/10
background, C57BL/10-mdx) and C57BL/6J mice were maintained
following the authorization of the National Institute of Health and Local
Committee (10/13-2014/2015); E18 fetuses were collected from both
mdx and C57BL/6J mice. Muscle samples were frozen in liquid
nitrogen, cooled in isopentane, and sectioned using a cryostat. The
analysis was performed on lower limb muscles. For murine
morphological analysis, the entire limb was cryosectioned at the leg
level.
Immunohistochemistry
Serial 10-μm-thick sections were stained with H&E, AM, AR (Meola,
2005) and AP (Grim and Carlson, 1990). For immunofluorescence
analysis, slides were incubated with primary antibodies against the
following: MyHC-developmental (NCL-MHCd), MyHC-neonatal (NCL-
MHCn), MyHC-fast (NCL-MHCf) and MyHC-slow (NCL-MHCs)
(1:20, Leica); laminin (1:100, L8271, Sigma); desmin (1:100, Abcam,
ab8592); Pax7 and Pax3 (1:100, Developmental Studies Hybridoma
Bank, AB 528428) and anti-active caspase 3 (1:50, Abcam, ab2302).
Detection was performed using Alexa Fluor-conjugated secondary
antibodies at 4 μg/ml (Molecular Probes). Images were captured using
the Leica TCS SP2 confocal system (Leica). For immunohistochemistry,
the same primary antibodies were used with Vector SG (gray; for
MyHC-slow) and Vector VIP (pink; for MyHC-fast) peroxidase kits,
followed by Vectastain ABC reagent and 3,3′-diaminobenzidine (all
Vector Laboratories). ImageJ software (NIH; http://rsbweb.nih.gov/ij/)
was used for image quantification analysis. For calcium imaging, slides
were incubated overnight with 5 µM Fluo-4 (Life Technologies) and
extensively washed before image capture with a fluorescence microscope
(Leica DMIRE2). This protocol was modified from other published data
for live tissue imaging (Ding, 2012).
Fig. 8. Modulation of protein expression in DMD fetal muscles. (A,B) Histogram representing the ratio between RYR1 andGAPDH (A) and between IP3R and
GAPDH (B), measured byWB analysis. (C) ELISA quantification of IP3 showed higher expression in fetal DMD compared with healthy muscles. (D) WB analysis
of human fetal healthy and dystrophic samples for the expression of β-actin, phosphorylated PKCα and total PKCα. HeLa cells (CTR1) and brain tissue from
C57BL/6J (CTR2) were used as positive controls. LC indicates loading control. (E) Histogram representing the ratio between phosphorylated and total PKCα,
measured by WB analysis. (F) Histogram of emission obtained using the PepTag Assay shows that the proportion of phosphorylated PKCα was greater in DMD
fetal muscle, indicating that the PKCα pathway is more activated in DMD than in healthy fetal muscles. Data are expressed as mean±s.d.; *P<0.05, **P<0.005,
***P<0.001.
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Analysis of morphometrical features of DMD and CTR fetal
muscle tissues
Images were captured by Leica microdissector (LMD 6500), fluorescence
microscope (Leica DMIRE2) and confocal microscope (Leica TCS-SP2).
For quantitative analysis, ImageJ software (NIH) was used. For
quantification analysis, 30 sections from each human biopsy were
analyzed. For fiber density analysis, the quantification was achieved by
counting fiber number in H&E-stained samples over a fixed grid area in 30
sections from each human biopsy (n=3), and by counting the H&E-stained
area versus the white space (extracellular space) within fibers in a fixed grid
area. Manual counting of fiber area was performed using ImageJ software.
Slow and fast MyHC+ fiber area was counted on 30 sections from each
human biopsy (n=3). AR staining was quantified using the Threshold color
Plug in of ImageJ software as the percentage of red stained area over a fixed
grid area. For the analysis of MyHC fiber expression, the neonatal/
developmental/fast/slow MyHC+ fibers were counted and expressed as a
percentage of the total number of laminin+ myofibers over a fixed grid area.
For the analysis of Pax7 expression, the Pax7+ cells were counted and their
number was expressed relative to the number of the desmin+ myofibers over
a fixed grid area.
Western blot analysis
Total protein concentration of muscle tissue samples from normal and DMD
fetuses; brain and testis of C57BL/6J; C57BL/6J and mdx E18 fetuses; rat
skeletal muscle, cerebrum and cerebellum was determined as previously
described (Parolini et al., 2009). Samples were resolved on an 8%
polyacrylamide gel and transferred to supported nitrocellulose membranes
(Bio-Rad Laboratories). Next, the filters were incubated overnight at 4°C
with the following primary antibodies: anti-phospho-PKCα (1:1000;
Millipore, 06-822); anti-PKCα (1:1000; BD Biosciences, 610107); anti-
CaMKII (1:500; Cell Signaling, 3362); anti-phospho-CaM Kinase II
(1:1000; Thermo Scientific, MA1-047) to detect the CaMKII protein
phosphorylated at threonine-286; anti-TRPC1 (1:500; Santa Cruz
Biotechnology, sc-23011); anti-Ryr1 (1:500; LifeSpan Biosciences,
LS-C153542); anti-Pax7 (1:500; Developmental Studies Hybridoma
Bank, AB 528428); anti-IP3R (1:500; Abcam, 155804); anti-MyoD
(1:500; BD Biosciences, 554130). Then, the filters were washed, detected
with horseradish peroxidase (HRP)-conjugated secondary antibodies
(Dako) and developed by ECL (Amersham Biosciences). Densitometric
analyses were performed using ImageJ software.
Quantification of phosphorylated PKCα
Phosphorylation of PKCα was analyzed using a PepTag Assay for Non-
Radioactive Detection of Protein Kinase C (Promega). For each muscle,
0.2-g samples were processed according to the manufacturer’s instructions.
To separate phosphorylated from non-phosphorylated PKCα, samples were
loaded onto a horizontal agarose gel: corresponding bands were cut and
quantified by a spectrofluorometer.
RT-qPCR
Total RNA was extracted from muscles of mdx and C57BL/6J fetuses,
dystrophic and normal fetal muscle tissues, and adult normal muscle. First-
strand cDNA was prepared as previously published (Benchaouir et al.,
2007). Primers used are listed in Table S1, as published by Richard et al.
(2011). The expression levels of each gene were measured using SYBR
Green. Analyses were performed from different muscle samples in duplicate
cDNA samples. Threshold cycles (Ct) of target genes were normalized
against the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), and relative transcript levels were calculated from the Ct values
as X=2−Δct where X is the fold difference in amount of target gene versus
GAPDH and ΔCt=Cttarget−CtGAPDH.
ELISA
The expression of IP3 was determined on fetal human and murine normal
and dystrophic muscles using a mouse inositol 1,4,5,-trisphosphate (IP3)
ELISA Kit (CusaBio, Wuhan, China). Frozen tissue sample homogenates
were prepared as indicated by the supplier and the assay procedure was run
as suggested (CusaBio). Samples and standards absorbancewas read using a
‘GloMax Discover’ microplates reader (Promega). Results were calculated
by plotting the mean absorbance for each standard using the professional
soft ‘Curve expert 1.3’ provided by CusaBio.
Statistical analysis
Data were analyzed using Graph Pad Prism (statistical program). Data were
expressed as mean±s.d. Fiber counts in mice were compared using
Student’s t-test. To compare multiple group means, one-way analysis of
variance (ANOVA) was used. When only two groups were compared, the
t-test was applied assuming equal variances. Fisher’s Exact Test was used
to compare the proportion of MyHC-expressing myofibers in CTR and
DMD samples. The difference between groups was considered significant
at P≤0.05.
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Fig. 9. A proposed model of PLC/IP3/IP3R/Ryr1/Ca2+/PKCα-dependent
pathway in DMD fetal muscle. Normally, the dihydropyridine receptor
(DHPR) is associatedwith RYR1: this complex is linked to aGi protein, which in
turn activates the PLC protein, regulating the levels of IP3. It is known that the
binding between G proteins and α-syntrophin (αSYN) exerts modulatory
effects on PLC signaling activity. As the absence of dystrophin in DMD
muscles has as primary consequence the absence of α-syntrophin, this PLC-
dependent pathway is disrupted and IP3 is overexpressed. This way, IP3
induces massive calcium release via IP3R activation of PKCα. When
phosphorylated, PKCα is responsible for a perturbation of MRF expression,
which causes the delay in myofiber maturation and the rearrangement of the
expression of fast-specific genes. All the proteins that we found to be
overexpressed in DMD fetal muscles are red.
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andBouché, M. (2012). PKC theta ablation improves healing in amousemodel of
muscular dystrophy. PLoS ONE 7, e31515.
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